{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:25:37Z","timestamp":1763036737724},"reference-count":88,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.berh.2013.01.004","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T06:11:15Z","timestamp":1363414275000},"page":"19-31","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Infections in vasculitis"],"prefix":"10.1016","volume":"27","author":[{"given":"Lo\u00efc","family":"Guillevin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1423-0410.1970.tb01550.x","article-title":"Hepatitis associated antigen and periarteritis nodosa (PAN)","volume":"19","author":"Trepo","year":"1970","journal-title":"Vox Sanguinis"},{"issue":"7684","key":"10.1016\/j.berh.2013.01.004_bib2","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(70)90339-9","article-title":"Association between polyarteritis and Australia antigen","volume":"2","author":"Gocke","year":"1970","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.berh.2013.01.004_bib3","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.01.004_bib5","first-page":"S373","article-title":"Identification of a Burkholderia-like strain from temporal arteries of subjects with giant cell arteritis","volume":"64","author":"Koening","year":"2012","journal-title":"Arthritis & Rheumatism"},{"issue":"203","key":"10.1016\/j.berh.2013.01.004_bib6","first-page":"292","article-title":"Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases","volume":"51","author":"Scott","year":"1982","journal-title":"Quarterly Journal of Medicine"},{"issue":"19","key":"10.1016\/j.berh.2013.01.004_bib7","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1001\/jama.1980.03310190032017","article-title":"Vasculitis in Eskimos living in an area hyperendemic for hepatitis B","volume":"244","author":"McMahon","year":"1980","journal-title":"The Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.20928","article-title":"Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register","volume":"53","author":"Reinhold-Keller","year":"2005","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","article-title":"Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate","volume":"51","author":"Mahr","year":"2004","journal-title":"Arthritis & Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.md.0000180792.80212.5e","article-title":"Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients","volume":"84","author":"Guillevin","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.berh.2013.01.004_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.27240","article-title":"Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database","volume":"62","author":"Pagnoux","year":"2010","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197601000-00001","article-title":"Vasculitis with hepatitis B antigenemia: long-term observation in nine patients","volume":"55","author":"Sergent","year":"1976","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib13","first-page":"876","article-title":"Regressing microaneurysms in 5 cases of hepatitis B virus related polyarteritis nodosa","volume":"22","author":"Darras-Joly","year":"1995","journal-title":"The Journal of Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2013.01.004_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/rheumatology\/27.4.258","article-title":"Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients","volume":"27","author":"Guillevin","year":"1988","journal-title":"British Journal of Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2013.01.004_bib15","first-page":"289","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients","volume":"20","author":"Guillevin","year":"1993","journal-title":"The Journal of Rheumatology"},{"issue":"30","key":"10.1016\/j.berh.2013.01.004_bib16","first-page":"1527","article-title":"Superiorit\u00e9 d'un nouveau traitement \u00e9tiopathog\u00e9nique curateur des p\u00e9riarterites noueuses induites par le virus de l'hepatite B gr\u00e2ce a l'association corticoth\u00e9rapie br\u00e8ve, vidarabine, \u00e9changes plasmatiques","volume":"17","author":"Trepo","year":"1988","journal-title":"La Presse M\u00e9dicale"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/jaut.2000.0502","article-title":"Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis","volume":"16","author":"Trepo","year":"2001","journal-title":"Journal of Autoimmunity"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0168-8278(00)00088-X","article-title":"Successful combination therapy of polyarteritis nodosa associated with a pre-core promoter mutant hepatitis B virus infection","volume":"34","author":"Wartelle-Bladou","year":"2001","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.berh.2013.01.004_bib19","first-page":"567","volume":"18","author":"Guillevin","year":"1991","journal-title":"The Journal of Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/ard.53.5.334","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges","volume":"53","author":"Guillevin","year":"1994","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00004836-199504000-00026","article-title":"Successful treatment of hepatitis B virus-associated polyarteritis nodosa by interferon alpha alone","volume":"20","author":"Simsek","year":"1995","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"4","key":"10.1016\/j.berh.2013.01.004_bib22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0168-8278(97)80263-2","article-title":"Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b","volume":"26","author":"Kruger","year":"1997","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/RHU.0b013e3181571944","article-title":"Lamivudine in the treatment of hepatitis B virus-related polyarteritis nodosa","volume":"13","author":"Auguet","year":"2007","journal-title":"Journal of Clinical Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/art.20401","article-title":"Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa","volume":"51","author":"Guillevin","year":"2004","journal-title":"Arthritis & Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2013.01.004_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0168-8278(00)80025-2","article-title":"Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine","volume":"33","author":"Erhardt","year":"2000","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1016\/j.berh.2013.01.004_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/rheumatology\/38.2.183","article-title":"Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha","volume":"38","author":"Wicki","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/acr.20381","article-title":"Hepatitis C virus-associated polyarteritis nodosa","volume":"63","author":"Saadoun","year":"2011","journal-title":"Arthritis Care & Research (Hoboken)"},{"issue":"7","key":"10.1016\/j.berh.2013.01.004_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-116-7-605_2","article-title":"Polyarteritis nodosa and hepatitis C virus infection","volume":"116","author":"Cacoub","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/BOR.0b013e32835b15f7","article-title":"Cryoglobulinemia vasculitis: an update","volume":"25","author":"Terrier","year":"2013","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1016\/j.berh.2013.01.004_bib31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ki.1995.78","article-title":"Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis","volume":"47","author":"Tarantino","year":"1995","journal-title":"Kidney International"},{"issue":"6","key":"10.1016\/j.berh.2013.01.004_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis & Rheumatism"},{"issue":"19","key":"10.1016\/j.berh.2013.01.004_bib33","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.166.19.2101","article-title":"Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia","volume":"166","author":"Saadoun","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"25","key":"10.1016\/j.berh.2013.01.004_bib34","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1182\/blood-2011-12-396028","article-title":"Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey","volume":"119","author":"Terrier","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.berh.2013.01.004_bib35","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus\u2013associated mixed cryoglobulinemia vasculitis: a long-term followup study","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis & Rheumatism"},{"issue":"10","key":"10.1016\/j.berh.2013.01.004_bib36","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V90.10.3865","article-title":"Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection","volume":"90","author":"Casato","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.berh.2013.01.004_bib37","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/art.30319","article-title":"Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis","volume":"63","author":"Terrier","year":"2011","journal-title":"Arthritis & Rheumatism"},{"issue":"8","key":"10.1016\/j.berh.2013.01.004_bib38","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/art.24703","article-title":"Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients","volume":"60","author":"Terrier","year":"2009","journal-title":"Arthritis & Rheumatism"},{"issue":"10","key":"10.1016\/j.berh.2013.01.004_bib39","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.berh.2013.01.004_bib40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-{alpha}, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib41","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib42","first-page":"121","article-title":"HIV-related vasculitis: clinical presentation and therapeutic approach on six patients","volume":"11","author":"Gisselbrecht","year":"1997","journal-title":"AIDS"},{"issue":"Suppl. 3","key":"10.1016\/j.berh.2013.01.004_bib43","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.aids.0000327513.53255.17","article-title":"Vasculitides in the context of HIV infection","volume":"22","author":"Guillevin","year":"2008","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005792-199409000-00003","article-title":"Cytomegalovirus vasculitis. Case reports and review of the literature","volume":"73","author":"Golden","year":"1994","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.berh.2013.01.004_bib45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00467-004-1736-1","article-title":"Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient","volume":"20","author":"Bilge","year":"2005","journal-title":"Pediatric Nephrology"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib46","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1086\/432578","article-title":"Primary cytomegalovirus infection, atypical Kawasaki disease, and coronary aneurysms in 2 infants","volume":"41","author":"Catalano-Pons","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"8917","key":"10.1016\/j.berh.2013.01.004_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(94)93030-9","article-title":"Polyarteritis nodosa and parvovirus B19","volume":"344","author":"Leruez-Ville","year":"1994","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib48","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","journal-title":"Arthritis & Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.md.0000180793.80212.17","article-title":"Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients","volume":"84","author":"Bourgarit","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.berh.2013.01.004_bib50","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/00365540500540475","article-title":"Multiple opportunistic infections after high-dose steroid therapy for giant cell arteritis in a patient previously treated with a purine analog","volume":"38","author":"Sendi","year":"2006","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.berh.2013.01.004_bib52","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.lpm.2012.06.008","article-title":"Comment traiter une vascularite n\u00e9crosante?","volume":"41","author":"Guillevin","year":"2012","journal-title":"La Presse M\u00e9dicale"},{"issue":"10","key":"10.1016\/j.berh.2013.01.004_bib53","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.lpm.2012.06.007","article-title":"Granulomatose avec polyangeite (maladie de Wegener)","volume":"41","author":"Karras","year":"2012","journal-title":"La Presse M\u00e9dicale"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib55","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.30296","article-title":"Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides","volume":"63","author":"Le Guenno","year":"2011","journal-title":"Arthritis & Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","article-title":"Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis","volume":"124","author":"Talar-Williams","year":"1996","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1016\/j.berh.2013.01.004_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard.2008.088302","article-title":"Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients","volume":"68","author":"Charlier","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"8","key":"10.1016\/j.berh.2013.01.004_bib58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/ard.56.8.481","article-title":"Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide","volume":"56","author":"Martin-Suarez","year":"1997","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00002281-199701000-00008","article-title":"Chronic immunosuppressive therapy for systemic vasculitis","volume":"9","author":"Langford","year":"1997","journal-title":"Current Opinion in Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2013.01.004_bib60","first-page":"615","article-title":"Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis","volume":"11","author":"Jarrousse","year":"1993","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"12","key":"10.1016\/j.berh.2013.01.004_bib61","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/ard.54.12.991","article-title":"Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis","volume":"54","author":"Godeau","year":"1995","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3 Pt 1","key":"10.1016\/j.berh.2013.01.004_bib62","first-page":"795","article-title":"Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis","volume":"151","author":"Ognibene","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1016\/j.berh.2013.01.004_bib63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/rheumatology\/keg066","article-title":"Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis","volume":"42","author":"Flores-Suarez","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.berh.2013.01.004_bib64","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1016\/j.berh.2013.01.004_bib65","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/1529-0131(200012)43:12<2853::AID-ANR30>3.0.CO;2-G","article-title":"Cystitis, bladder cancer, and myelodysplasia in patients with Wegener's granulomatosis: comment on the article by Reinhold-Keller et\u00a0al","volume":"43","author":"Sneller","year":"2000","journal-title":"Arthritis & Rheumatism"},{"issue":"12","key":"10.1016\/j.berh.2013.01.004_bib66","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/rheumatology\/36.12.1290","article-title":"Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides","volume":"36","author":"Gayraud","year":"1997","journal-title":"British Journal of Rheumatology"},{"issue":"12","key":"10.1016\/j.berh.2013.01.004_bib67","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis & Rheumatism"},{"issue":"10","key":"10.1016\/j.berh.2013.01.004_bib68","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"The New England Journal of Medicine"},{"issue":"1 Suppl. 70","key":"10.1016\/j.berh.2013.01.004_bib70","first-page":"S83","article-title":"Immunogenicity and safety of seasonal and 2009 pandemic A\/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients","volume":"30","author":"Kostianovsky","year":"2012","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"7","key":"10.1016\/j.berh.2013.01.004_bib71","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1016\/j.berh.2013.01.004_bib72","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib73","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1 Suppl. 64","key":"10.1016\/j.berh.2013.01.004_bib74","first-page":"S63","article-title":"Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients","volume":"29","author":"de Menthon","year":"2011","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2013.01.004_bib76","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","author":"Guillevin","year":"2012","journal-title":"Arthritis & Rheumatism"},{"issue":"7","key":"10.1016\/j.berh.2013.01.004_bib77","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/art.24637","article-title":"A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Jones","year":"2009","journal-title":"Arthritis & Rheumatism"},{"issue":"8","key":"10.1016\/j.berh.2013.01.004_bib78","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.62.8.791","article-title":"French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers","volume":"62","author":"Mariette","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1016\/j.berh.2013.01.004_bib79","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3324\/haematol.10564","article-title":"Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen","volume":"92","author":"Kolstad","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib80","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0609.2007.00994.x","article-title":"Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma","volume":"80","author":"Venhuizen","year":"2008","journal-title":"European Journal of Haematology"},{"issue":"2","key":"10.1016\/j.berh.2013.01.004_bib81","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.seminhematol.2010.01.002","article-title":"Rituximab-associated infections","volume":"47","author":"Gea-Banacloche","year":"2010","journal-title":"Seminars in Hematology"},{"issue":"4","key":"10.1016\/j.berh.2013.01.004_bib82","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12185-008-0168-2","article-title":"Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature","volume":"88","author":"Yokoyama","year":"2008","journal-title":"International Journal of Hematology"},{"issue":"8","key":"10.1016\/j.berh.2013.01.004_bib83","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2165\/11209490-000000000-00000","article-title":"Immune globulin subcutaneous (human) 20%: in primary immunodeficiency disorders","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.berh.2013.01.004_bib84","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/rheumatology\/ker389","article-title":"Protective effect of A\/H1N1 vaccination in immune-mediated disease\u2013a prospectively controlled vaccination study","volume":"51","author":"Adler","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.berh.2013.01.004_bib85","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1016\/j.berh.2013.01.004_bib86","first-page":"72","article-title":"Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3","volume":"2004","author":"Wr","year":"2004","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib87","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2011090920","article-title":"High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"23","author":"Kain","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1016\/j.berh.2013.01.004_bib88","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"The New England Journal of Medicine"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T10:54:06Z","timestamp":1715079246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694213000077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1521694213000077"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2013.01.004","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections in vasculitis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2013.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}